AP
Alta Partners
Venture CapitalActiveAlta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996.
225
Investments
67
Exits
$3.2B
AUM
29.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Alta Partners.
Investment Thesis & Strategy
Alta Partners invests in life sciences companies across various stages, seeking to fund innovative companies in the life sciences industry.
Investment Activity
Deals per year over the last 5 years
1
20052
20061
20070
20081
2009Portfolio Companies
Selected investments from their portfolio of 225 companies
O
Onyx Pharmaceuticals
Biotech · Growth, 0
A
Alteon
Biotech · Growth, 0
G
Gilead Sciences
Biotech · Growth, 0
G
Genentech
Biotech · Growth, 0
C
Corcept Therapeutics
Biotech · Growth, 0
S
Sangamo Therapeutics
Biotech · Growth, 0
N
Neurocrine Biosciences
Biotech · Growth, 0
A
Aragon Pharmaceuticals
Biotech · Growth, 2009
A
Ambit Biosciences
Biotech · Growth, 2007
M
MAP Pharmaceuticals
Biotech · Growth, 2006
P
Portola Pharmaceuticals
Biotech · Growth, 2006
P
Pharmacyclics
Biotech · Growth, 2005
Frequently Asked Questions
Alta Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals